Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 11Terminated 5Unknown 4Recruiting 4Active not recruiting 4Withdrawn 3Enrolling by invitation 1

Sponsor Class

NIH 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 3

Conditions

Uterine Cervical Neoplasms 3Papillomavirus Infections 3HIV Infections 1

Interventions

pembrolizumab 436Carboplatin 321Nivolumab 287Cyclophosphamide 280Specimen Handling 257Cisplatin 251Paclitaxel 248Magnetic Resonance Spectroscopy 248Radiotherapy 217Gemcitabine 180Dexamethasone 180Biopsy 177durvalumab 166atezolizumab 148Rituximab 138Lenalidomide 134Doxorubicin 134Docetaxel 130Bevacizumab 129Ipilimumab 125Radiation 118Capecitabine 117Pemetrexed 112Oxaliplatin 112Etoposide 111Radiosurgery 108Fluorouracil 108venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Colposcopy × Clear all
NCT06498661 2026-05-13

SHIP-A-S01

National Cancer Institute (NCI)

Phase NA Active not recruiting
750 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611540 2026-05-13

LMI-001-A-S03

National Cancer Institute (NCI)

Phase NA Active not recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611553 2026-05-13

LMI-001-A-S02

National Cancer Institute (NCI)

Phase NA Active not recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT05074264 2025-11-10

CAMPO-101

University of California, San Francisco

Phase NA Active not recruiting
1,586 enrolled

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡